| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1002609592 |
| P356 | DOI | 10.1007/S12325-016-0302-0 |
| P932 | PMC publication ID | 4846688 |
| P698 | PubMed publication ID | 26909513 |
| P5875 | ResearchGate publication ID | 295861119 |
| P50 | author | Banu Bozkurt | Q50633485 |
| Luca Rossetti | Q51949225 | ||
| Anastasios G P Konstas | Q89460814 | ||
| Julian Garcia Feijoo | Q41638671 | ||
| P2093 | author name string | Norbert Pfeiffer | |
| Andreas Katsanos | |||
| Luciano Quaranta | |||
| Stefano Miglior | |||
| Tarek Shaarawy | |||
| P2860 | cites work | Flow of aqueous humor in humans [The Friedenwald Lecture] | Q28300984 |
| Impact of intraocular pressure regulation on visual fields in open-angle glaucoma | Q30699739 | ||
| Selective laser trabeculoplasty v argon laser trabeculoplasty: a prospective randomised clinical trial | Q30701038 | ||
| Selective vs argon laser trabeculoplasty: hypotensive efficacy, anterior chamber inflammation, and postoperative pain. | Q31058984 | ||
| Role of argon laser trabeculoplasty as primary and secondary therapy in open angle glaucoma in Indian patients | Q31088218 | ||
| Comparison of long-term outcomes of selective laser trabeculoplasty versus argon laser trabeculoplasty in open-angle glaucoma | Q31118521 | ||
| Daytime fluctuation of intraocular pressure in patients with primary angle-closure glaucoma after trabeculectomy. | Q45346346 | ||
| 24-hour efficacy of the bimatoprost-timolol fixed combination versus latanoprost as first choice therapy in subjects with high-pressure exfoliation syndrome and glaucoma | Q45759968 | ||
| Tolerability, quality of life, and persistency of use in patients with glaucoma who are switched to the fixed combination of latanoprost and timolol. | Q45991334 | ||
| 24-hour intraocular pressure and blood pressure levels with latanoprost/timolol fixed combination versus timolol. | Q46032736 | ||
| Dampening of diurnal intraocular pressure fluctuation by combined trabeculotomy and sinusotomy in eyes with open-angle glaucoma | Q46094814 | ||
| Intraocular pressure control over 24 hours using travoprost and timolol fixed combination administered in the morning or evening in primary open-angle and exfoliative glaucoma | Q46141402 | ||
| Nocturnal elevation of intraocular pressure in young adults. | Q46324657 | ||
| 24-hour intraocular pressures with brimonidine purite versus dorzolamide added to latanoprost in primary open-angle glaucoma subjects | Q46420044 | ||
| Twenty-four-hour intraocular pressure and blood pressure levels with bimatoprost versus latanoprost in patients with normal-tension glaucoma. | Q46513068 | ||
| Twenty-four-hour control with latanoprost-timolol-fixed combination therapy vs latanoprost therapy | Q46595120 | ||
| Comparison of twice-daily and three-times-daily dosing of dorzolamide in ocular hypertension and primary open-angle glaucoma patients treated with latanoprost. | Q46680024 | ||
| Comparison of the 24-hour intraocular pressure-lowering effects of latanoprost and dorzolamide/timolol fixed combination after 2 and 6 months of treatment | Q46827535 | ||
| Circadian changes of intraocular pressure and ocular perfusion pressure after timolol or latanoprost in Caucasians with normal-tension glaucoma | Q46899245 | ||
| 24-hour intraocular pressure control obtained with evening- versus morning-dosed travoprost in primary open-angle glaucoma | Q46972832 | ||
| Twenty-four-hour intraocular pressure pattern associated with early glaucomatous changes | Q46985585 | ||
| Increase of peak intraocular pressure during sleep in reproduced diurnal changes by posture | Q48513150 | ||
| Effects of topical hypotensive drugs on circadian IOP, blood pressure, and calculated diastolic ocular perfusion pressure in patients with glaucoma | Q48624676 | ||
| The effect of dorzolamide on aqueous humor dynamics in normal human subjects during sleep | Q48789479 | ||
| Effects of timolol, epinephrine, and acetazolamide on aqueous flow during sleep | Q49034505 | ||
| Aqueous humor flow during sleep. | Q49075243 | ||
| Latanoprost: experience of 2-year treatment in Scandinavia. | Q50513414 | ||
| Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning. A comparison with timolol. Scandinavian Latanoprost Study Group. | Q50755447 | ||
| A double-masked, randomized 1-year study comparing dorzolamide (Trusopt), timolol, and betaxolol. International Dorzolamide Study Group. | Q53373965 | ||
| Five-year risk of progression of ocular hypertension to primary open angle glaucoma. A population-based study. | Q53848818 | ||
| Answers from the ocular hypertension treatment study. | Q53872475 | ||
| Evaluation of continuous 24-hour intraocular pressure monitoring for assessment of prostaglandin-induced pressure reduction in glaucoma | Q87003043 | ||
| Long-term 24-hour intraocular pressure control with travoprost monotherapy in patients with primary open-angle glaucoma | Q87790496 | ||
| The Effect of Latanoprost, Brimonidine, and a Fixed Combination of Timolol and Dorzolamide on Circadian Intraocular Pressure in Patients With Glaucoma or Ocular Hypertension | Q44403526 | ||
| Comparison of the nocturnal effects of once-daily timolol and latanoprost on intraocular pressure | Q44414154 | ||
| A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter study | Q44420267 | ||
| Effects of several anti-glaucoma medications on the circadian intraocular pressure fluctuations in patients with primary open-angle glaucoma | Q44482458 | ||
| Twenty-four-hour diurnal curve comparison of commercially available latanoprost 0.005% versus the timolol and dorzolamide fixed combination | Q44516155 | ||
| 24-Hour IOP control with once-daily bimatoprost, timolol gel-forming solution, or latanoprost: a 1-month, randomized, comparative clinical trial | Q44796835 | ||
| Effects on aqueous flow of dorzolamide combined with either timolol or acetazolamide | Q44876318 | ||
| Daytime diurnal curve comparison between the fixed combinations of latanoprost 0.005%/timolol maleate 0.5% and dorzolamide 2%/timolol maleate 0.5%. | Q44952434 | ||
| Intraocular pressure lowering efficacy of travoprost | Q45125874 | ||
| Latanoprost 0.005% versus bimatoprost 0.03% in primary open-angle glaucoma patients | Q45251067 | ||
| Argon laser trabeculoplasty controls one third of cases of progressive, uncontrolled, open angle glaucoma for 5 years | Q31137645 | ||
| Q-switched 532-nm Nd:YAG laser trabeculoplasty (selective laser trabeculoplasty): a multicenter, pilot, clinical study | Q31974311 | ||
| The role of diurnal pressure measurements in the management of open angle glaucoma | Q33199541 | ||
| Diurnal variation of intraocular pressure and its correlation with retinal nerve fiber analysis in Turkish patients with exfoliation syndrome | Q33220900 | ||
| A comparison of the circadian rhythm of intraocular pressure in primary phronic angle closure glaucoma, primary open angle glaucoma and normal eyes. | Q33228748 | ||
| Effect of laser trabeculoplasty on nocturnal intraocular pressure in medically treated glaucoma patients | Q33267577 | ||
| Mechanisms of action and efficacy of argon laser trabeculoplasty and selective laser trabeculoplasty. | Q33273852 | ||
| Predictors of long-term progression in the early manifest glaucoma trial | Q33290742 | ||
| Intraocular pressure fluctuation a risk factor for visual field progression at low intraocular pressures in the advanced glaucoma intervention study | Q33310539 | ||
| Quality of diurnal intraocular pressure control in primary open-angle patients treated with latanoprost compared with surgically treated glaucoma patients: a prospective trial | Q33315741 | ||
| Canadian Glaucoma Study: 2. risk factors for the progression of open-angle glaucoma | Q33359342 | ||
| Selective laser trabeculoplasty: a review | Q33369719 | ||
| Long-term effects of latanoprost monotherapy on intraocular pressure in Japanese glaucoma patients | Q33394186 | ||
| Efficacy and tolerability of prostaglandin analogs: a meta-analysis of randomized controlled clinical trials | Q33394187 | ||
| Intraocular pressure control and fluctuation: the effect of treatment with selective laser trabeculoplasty | Q33395580 | ||
| A comparison of the intervisit intraocular pressure fluctuation after 180 and 360 degrees of selective laser trabeculoplasty (SLT) as a primary therapy in primary open angle glaucoma and ocular hypertension | Q33410232 | ||
| Intraocular pressure measurements throughout the 24 h. | Q33412082 | ||
| Repeat selective laser trabeculoplasty | Q33419262 | ||
| Selective laser trabeculoplasty versus argon laser trabeculoplasty in patients with uncontrolled open-angle glaucoma. | Q33435440 | ||
| Influence of selective laser trabeculoplasty on 24-hour diurnal intraocular pressure fluctuation in primary open-angle glaucoma: a pilot study | Q33589024 | ||
| Diurnal variations in intraocular pressure | Q34164636 | ||
| DIURNAL TONOGRAPHY IN NORMAL AND GLAUCOMATOUS EYES. | Q34204701 | ||
| Effects of prostaglandin analogues on aqueous humor outflow pathways | Q34393424 | ||
| Intraocular pressure-lowering effects of commonly used fixed-combination drugs with timolol: a systematic review and meta-analysis | Q34428023 | ||
| Brimonidine 0.2% versus dorzolamide 2% each given three times daily to reduce intraocular pressure | Q34510023 | ||
| Intraocular pressure-lowering effects of all commonly used glaucoma drugs: a meta-analysis of randomized clinical trials | Q34557995 | ||
| Emerging perspectives in glaucoma: optimizing 24-hour control of intraocular pressure | Q34659383 | ||
| Comparison of fluctuations of intraocular pressure before and after selective laser trabeculoplasty in normal-tension glaucoma patients | Q35046133 | ||
| 24-hour monitoring of intraocular pressure in glaucoma management: a retrospective review | Q35143537 | ||
| A randomised, prospective study comparing selective laser trabeculoplasty with latanoprost for the control of intraocular pressure in ocular hypertension and open angle glaucoma | Q35593945 | ||
| Twenty-four hour efficacy with the dorzolamide/timolol-fixed combination compared with the brimonidine/timolol-fixed combination in primary open-angle glaucoma | Q35676220 | ||
| Correlation between office and peak nocturnal intraocular pressures in healthy subjects and glaucoma patients | Q36055932 | ||
| Argon laser therapy for open-angle glaucoma. A pilot study | Q36572705 | ||
| Effect of argon laser trabeculoplasty on the glaucomatous diurnal curve | Q36622621 | ||
| Long-term functional outcome after early surgery compared with laser and medicine in open-angle glaucoma. | Q36724463 | ||
| Diurnal fluctuation and concordance of intraocular pressure in glaucoma suspects and normal tension glaucoma patients | Q36793539 | ||
| Concordance of diurnal intraocular pressure between fellow eyes in primary open-angle glaucoma. | Q36805648 | ||
| 5-fluorouracil in combined trabeculectomy and clear-cornea phacoemulsification with posterior chamber intraocular lens implantation. A one-year randomized, controlled clinical trial | Q36848786 | ||
| 24-hour intraocular pressure in glaucoma patients randomized to receive dorzolamide or brinzolamide in combination with latanoprost. | Q37288768 | ||
| Diurnal intraocular pressure variations: an analysis of 690 diurnal curves | Q37297037 | ||
| The diurnal and nocturnal effect of travoprost with sofZia on intraocular pressure and ocular perfusion pressure | Q37490198 | ||
| Latanoprost ophthalmic solution in the treatment of open angle glaucoma or raised intraocular pressure: a review | Q37577392 | ||
| Twenty-four-hour effects of bimatoprost 0.01% monotherapy on intraocular pressure and ocular perfusion pressure | Q37634184 | ||
| The intraocular pressure-lowering effect of prostaglandin analogs combined with topical β-blocker therapy: a systematic review and meta-analysis | Q37771502 | ||
| Balancing efficacy and tolerability of prostaglandin analogues and prostaglandin-timolol fixed combinations in primary open-angle glaucoma. | Q37923962 | ||
| 24-hour intraocular pressure and ocular perfusion pressure in glaucoma. | Q38065385 | ||
| Prostaglandin analogs and timolol-fixed versus unfixed combinations or monotherapy for open-angle glaucoma: a systematic review and meta-analysis | Q38066567 | ||
| 24-hour control of intraocular pressure with 2% dorzolamide/0.5% timolol fixed-combination ophthalmic solution in open-angle glaucoma | Q38388658 | ||
| Twenty-four-hour pattern of intraocular pressure in the aging population | Q41700497 | ||
| The efficacy and safety of brinzolamide 1% ophthalmic suspension (Azopt) as a primary therapy in patients with open-angle glaucoma or ocular hypertension. Brinzolamide Primary Therapy Study Group | Q41718417 | ||
| Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma: a six-month masked, multicenter trial in the United States. The United States Latanoprost Study Group | Q42556526 | ||
| Peak intraocular pressure and glaucomatous progression in primary open-angle glaucoma. | Q42620687 | ||
| Comparison of the diurnal ocular hypotensive efficacy of travoprost and latanoprost over a 44-hour period in patients with elevated intraocular pressure | Q42621232 | ||
| Twenty-four hour control of intraocular pressure with dorzolamide and timolol maleate in exfoliation and primary open-angle glaucoma | Q42623524 | ||
| Comparison of the safety and efficacy of dorzolamide 2% and brimonidine 0.2% in patients with glaucoma or ocular hypertension | Q42625328 | ||
| A network meta-analysis combined direct and indirect comparisons between glaucoma drugs to rank effectiveness in lowering intraocular pressure | Q42632190 | ||
| Meta-analysis of 24-hour intraocular pressure studies evaluating the efficacy of glaucoma medicines | Q42639791 | ||
| The effect of latanoprost, bimatoprost, and travoprost on circadian variation of intraocular pressure in patients with open-angle glaucoma | Q42646512 | ||
| Efficacy and tolerability of timolol maleate ophthalmic gel-forming solution versus timolol ophthalmic solution in adults with open-angle glaucoma or ocular hypertension: a six-month, double-masked, multicenter study | Q42648057 | ||
| Effects of the timolol-dorzolamide fixed combination and latanoprost on circadian diastolic ocular perfusion pressure in glaucoma | Q42656864 | ||
| Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery | Q42664045 | ||
| Diurnal and nocturnal effects of brimonidine monotherapy on intraocular pressure | Q42669769 | ||
| Comparison of the effects of latanoprost, travoprost, and bimatoprost on circadian intraocular pressure in patients with glaucoma or ocular hypertension | Q42679648 | ||
| Continuous intraocular pressure monitoring with a wireless ocular telemetry sensor: initial clinical experience in patients with open angle glaucoma | Q42685701 | ||
| Short-term fluctuation of intraocular pressure is higher in patients with pseudoexfoliation syndrome despite similar mean intraocular pressure: a retrospective case-control study | Q42687752 | ||
| Meta-analysis of 24-h intraocular pressure fluctuation studies and the efficacy of glaucoma medicines | Q43119932 | ||
| A randomized, 36-month, post-marketing efficacy and tolerability study in Sweden and Finland of latanoprost versus non-prostaglandin therapy in patients with glaucoma or ocular hypertension | Q43245623 | ||
| Twenty-four-hour intraocular pressure control with bimatoprost and the bimatoprost/timolol fixed combination administered in the morning, or evening in exfoliative glaucoma | Q43262252 | ||
| Using diurnal intraocular pressure fluctuation to assess the efficacy of fixed-combination latanoprost/timolol versus latanoprost or timolol monotherapy | Q43289506 | ||
| Effect on intraocular pressure during 24 hours after repeated administration of the fixed combination of latanoprost 0.005% and timolol 0.5% in patients with ocular hypertension | Q43584361 | ||
| Brimonidine 0.2% given two or three times daily versus timolol maleate 0.5% in primary open-angle glaucoma | Q43625008 | ||
| Efficacy and safety of bimatoprost in patients with elevated intraocular pressure: a 30-day comparison with latanoprost | Q43660041 | ||
| Three-month comparison of bimatoprost and latanoprost in patients with glaucoma and ocular hypertension | Q43747342 | ||
| A comparison of once-daily morning vs evening dosing of concomitant latanoprost/timolol | Q44010297 | ||
| Effect of 0.005% latanoprost once daily on intraocular pressure in glaucomatous patients not adequately controlled by beta-blockers twice daily: a 3-year follow-up. Experience and incidence of side effects in a prospective study on 76 patients | Q44033975 | ||
| The effect of latanoprost on intraocular pressure during 2 years of treatment | Q44120787 | ||
| Comparison of 24 hour control with Timoptic 0.5% and Timoptic-XE 0.5% in exfoliation and primary open-angle glaucoma. | Q53922529 | ||
| Latanoprost. Two years' experience of its use in the United Kingdom. Latanoprost Study Group. | Q53960639 | ||
| Effect of timolol on the diurnal intraocular pressure in exfoliation and primary open-angle glaucoma. | Q53966147 | ||
| Diurnal intraocular pressure in untreated exfoliation and primary open-angle glaucoma. | Q53974150 | ||
| Prevalence, diagnostic features, and response to trabeculectomy in exfoliation glaucoma. | Q54048124 | ||
| 24-hour efficacy of travoprost/timolol BAK-free versus latanoprost/timolol fixed combinations in patients insufficiently controlled with latanoprost. | Q64888863 | ||
| The Glaucoma Laser Trial (GLT). 2. Results of argon laser trabeculoplasty versus topical medicines. The Glaucoma Laser Trial Research Group | Q68627065 | ||
| Pressure-curve variations after trabeculectomy for chronic primary open-angle glaucoma | Q68647250 | ||
| Self-tonometry to manage patients with glaucoma and apparently controlled intraocular pressure | Q69265834 | ||
| Individual variability in the diurnal intraocular pressure curve | Q70760027 | ||
| The effects of sleep on circulating catecholamines and aqueous flow in human subjects | Q71508288 | ||
| A comparison of the safety and efficacy of twice daily brimonidine 0.2% versus betaxolol 0.25% in subjects with elevated intraocular pressure. The Brimonidine Study Group III | Q71906621 | ||
| Four-week safety and efficacy study of dorzolamide, a novel, active topical carbonic anhydrase inhibitor | Q72546473 | ||
| [Principles of effectiveness control in therapy of glaucoma] | Q73002513 | ||
| Factors associated with long-term progression or stability in primary open-angle glaucoma | Q73044948 | ||
| The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration.The AGIS Investigators | Q73055302 | ||
| Assessment of diurnal tensional curve in early glaucoma damage | Q73251118 | ||
| Changes in intraocular pressure during prolonged (7-day) head-down tilt bedrest | Q73469771 | ||
| Large diurnal fluctuations in intraocular pressure are an independent risk factor in patients with glaucoma | Q73715057 | ||
| Effect of timolol, latanoprost, and dorzolamide on circadian IOP in glaucoma or ocular hypertension | Q74150874 | ||
| Fluctuations of intraocular pressure during the day in open-angle glaucoma, normal-tension glaucoma and normal subjects | Q74256455 | ||
| Factors associated with long-term progression or stability in exfoliation glaucoma | Q75244520 | ||
| THE DIURNAL VARIATIONS OF OCULAR TENSION IN GLAUCOMA | Q76897047 | ||
| Comparison of 24-hour intraocular pressure reduction with two dosing regimens of latanoprost and timolol maleate in patients with primary open-angle glaucoma | Q78245024 | ||
| Intraocular pressure fluctuations in medical versus surgically treated glaucomatous patients | Q78823897 | ||
| The significance of the diurnal tension variations in normal and glaucomatous eyes | Q78925918 | ||
| 24-Hour control with a latanoprost-timolol fixed combination vs timolol alone | Q79354727 | ||
| Circadian intraocular pressure control with dorzolamide versus timolol maleate add-on treatments in primary open-angle glaucoma patients using latanoprost | Q79428904 | ||
| Comparison of the effects of bimatoprost and a fixed combination of latanoprost and timolol on circadian intraocular pressure | Q80217526 | ||
| Relation between office intraocular pressure and 24-hour intraocular pressure in patients with primary open-angle glaucoma treated with a combination of topical antiglaucoma eye drops | Q80250800 | ||
| Effect of latanoprost on the diurnal variations in the intraocular and ocular perfusion pressure in normal tension glaucoma | Q80306671 | ||
| Twenty-four-hour efficacy of the brimonidine/timolol fixed combination versus therapy with the unfixed components | Q80482541 | ||
| Diurnal variation of intraocular pressure in suspected glaucoma patients and their outcome | Q81365985 | ||
| Sequential office pressure measurements in the management of glaucoma | Q81713834 | ||
| Diurnal and nocturnal intraocular pressure fluctuations after trabeculectomy | Q82468614 | ||
| Control of intraocular pressure and fluctuation with fixed-combination brimonidine-timolol versus brimonidine or timolol monotherapy | Q82626882 | ||
| Comparing the measurement of diurnal fluctuations in intraocular pressure in the same day versus over different days in glaucoma | Q82636574 | ||
| Circadian intraocular pressure and blood pressure reduction with timolol 0.5% solution and timogel 0.1% in patients with primary open-angle glaucoma | Q82645528 | ||
| Diurnal intraocular pressure profiles and progression of chronic open-angle glaucoma | Q83119845 | ||
| Bimatoprost and bimatoprost/timolol fixed combination in patients with open-angle glaucoma and ocular hypertension | Q83150066 | ||
| 24-hour intraocular pressure control with maximum medical therapy compared with surgery in patients with advanced open-angle glaucoma | Q83227268 | ||
| Comparison of dorzolamide/timolol and latanoprost/timolol fixed combinations on diurnal intraocular pressure control in primary open-angle glaucoma | Q83413274 | ||
| Clinical utility of intraocular pressure monitoring outside of normal office hours in patients with glaucoma | Q83977942 | ||
| Meta-analysis of timolol on diurnal and nighttime intraocular pressure and blood pressure | Q84275656 | ||
| Untreated 24-h intraocular pressures measured with Goldmann applanation tonometry vs nighttime supine pressures with Perkins applanation tonometry | Q84977531 | ||
| Comparison of 24-hour intraocular pressure reduction obtained with brinzolamide/timolol or brimonidine/timolol fixed-combination adjunctive to travoprost therapy | Q86527477 | ||
| Twenty-four hour efficacy with preservative free tafluprost compared with latanoprost in patients with primary open angle glaucoma or ocular hypertension | Q86814488 | ||
| P2507 | corrigendum / erratum | Erratum to: 24-h Efficacy of Glaucoma Treatment Options | Q42855947 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | glaucoma | Q159701 |
| vision disorder | Q767669 | ||
| disease management | Q883708 | ||
| P304 | page(s) | 481-517 | |
| P577 | publication date | 2016-04-01 | |
| P1433 | published in | Advances in Therapy | Q4686392 |
| P1476 | title | 24-h Efficacy of Glaucoma Treatment Options | |
| P478 | volume | 33 |
| Q37562459 | 24-Hour Efficacy and Ocular Surface Health with Preservative-Free Tafluprost Alone and in Conjunction with Preservative-Free Dorzolamide/Timolol Fixed Combination in Open-Angle Glaucoma Patients Insufficiently Controlled with Preserved Latanoprost M |
| Q53830693 | A Review of the Clinical Usefulness of Selective Laser Trabeculoplasty in Exfoliative Glaucoma. |
| Q57807191 | Diurnal and 24-h Intraocular Pressures in Glaucoma: Monitoring Strategies and Impact on Prognosis and Treatment |
| Q91781552 | Efficacy and Safety of Brinzolamide as Add-On to Prostaglandin Analogues or β-Blocker for Glaucoma and Ocular Hypertension: A Systematic Review and Meta-Analysis |
| Q42370199 | Fluctuation of intraocular pressure in glaucoma patients before and after trabeculectomy with mitomycin C. |
| Q47381165 | Preservative-Free Prostaglandin Analogs and Prostaglandin/Timolol Fixed Combinations in the Treatment of Glaucoma: Efficacy, Safety and Potential Advantages. |
| Q55362967 | The 24-hour intraocular pressure control by tafluprost/timolol fixed combination after switching from the concomitant use of tafluprost and timolol gel-forming solution, in patients with primary open-angle glaucoma. |
| Q64894608 | Transpalpebral Electrical Stimulation as a Novel Therapeutic Approach to Decrease Intraocular Pressure for Open-Angle Glaucoma: A Pilot Study. |
| Q64234852 | Twenty-Four-Hour Contact Lens Sensor Monitoring of Aqueous Humor Dynamics in Surgically or Medically Treated Glaucoma Patients |
| Q42855947 | Erratum to: 24-h Efficacy of Glaucoma Treatment Options | main subject | P921 |
Search more.